# Investor Relations Analyst — Amneal Pharmaceuticals

- Location: Bridgewater, NJ
- Posted pay: $80k–$100k/yr
- Posted: Nov 16, 2026
- Status: open (checked Nov 21, 2026)
- Apply (employer's site): https://hcfa.fa.us2.oraclecloud.com/hcmUI/CandidateExperience/en/sites/CX/job/9468
- Employer record: https://visajobs.io/company/amneal-pharmaceuticals.md

## Sponsorship history
- Tier: Employer history only
- Occupation (SOC): Financial and Investment Analysts (13-2051)
- Employer's certified LCAs for this occupation in NJ, FY2024–FY2026: 0
- …in the whole US: 0
- With this exact title: 0
- Median DOL prevailing wage, level I / II: $85k / $116k

## Description
Amneal is seeking an Investor Relations Analyst to provide specialized financial analysis, equity-market research, and pharmaceutical competitive intelligence in support of its investor relations program. The role applies financial statement analysis, corporate finance, valuation, and quantitative research to evaluate the Company's performance, market positioning, and long-term value creation opportunity. Working closely with the Head of Investor Relations and cross-functional partners, the Analyst will develop deep knowledge of Amneal's biosimilars business and translate financial, business, and market analysis into insights for investors, the Board of Directors, and senior leadership.
Essential Functions:
Strategic IR, Value Creation & Catalyst Planning
Analyze the financial drivers of the Company's investment narrative and value creation framework, linking growth, profitability, cash generation, capital allocation, and valuation to business strategy.
Maintain a catalyst roadmap of product launches, pipeline and regulatory milestones, and strategic developments; assess potential implications for financial performance, market expectations, and investor messaging.
Maintain the integrated IR calendar and press release schedule, aligning earnings, conferences, roadshows, and communications with business priorities, investor interests, and upcoming catalysts.
Investor Targeting & Relationship Management
Analyze institutional portfolios, investment mandates, sector exposure, and peer ownership to prioritize investor targets; maintain the Top 20 investor priority list and broader targeting universe, including retail.
Maintain the investor CRM, including contacts, ownership profiles, investment styles, meeting history, feedback, questions, and follow-up actions; use these records to evaluate engagement and refine targeting.
Prepare research-based investor profiles and meeting briefings; support outreach and follow-up by identifying relevant investment theses, valuation perspectives, and questions from current and prospective shareholders.
Analyst Research, Peer Analysis & Valuation
Analyze sell-side research, earnings models, consensus estimates, revisions, ratings, and price targets for Amneal and peers; identify underlying assumptions and emerging investor concerns.
Analyze peer financial statements and quarterly results, including Sandoz, Teva, and Viatris; compare growth, margins, cash flow, leverage, business drivers, strategic developments, and investor messaging.
Develop and maintain peer benchmarks and financial valuation models, including comparable-company multiples and sensitivity analyses, to evaluate relative performance, valuation gaps, and market expectations.
Market Activity & Shareholder Ownership
Analyze daily share-price performance, trading volume, and volatility relative to peers and market benchmarks, as necessary; assess potential links to company news, analyst revisions, sector developments, and broader market conditions.
Analyze institutional ownership changes, concentration, and investor style using shareholder filings and market data; prepare concise market and ownership updates.
Biosimilars & Industry Intelligence
Develop deep knowledge of Amneal's biosimilars portfolio, pipeline, development milestones, partnerships, manufacturing capabilities, and commercial strategy.
Evaluate biosimilar competitive dynamics, new entrants, pipelines, expected launches, regulatory developments, pricing, adoption, and addressable markets; assess potential implications for Amneal's growth and competitive positioning.
Develop market and pipeline trackers and financial scenario analyses using documented launch-timing, market-share, and pricing assumptions; translate findings into investment-relevant insights and management briefings.
Monitor GLP-1 and specialty medicine developments relevant to Amneal's investment narrative, including new specialty R&D therapeutic initiatives; validate business assumptions with internal subject-matter experts.
Investor Communications & IR Execution
Prepare financial analysis and supporting content for earnings releases, presentations, scripts, Q&A, investor materials, and IR website updates; validate figures and reconcile approved financial measures with Finance.
Support earnings calls, conferences, roadshows, investor days, and other IR events, including research, briefing materials, logistics, and follow-up.
Research investor questions and synthesize financial and industry information into proposed responses; coordinate with Finance, business leaders, and Legal to ensure accuracy and appropriate disclosure.
Board of Directors & Executive Leadership Communications
Support preparation of analytical reports and presentations for the Board of Directors and Executive Leadership Team (ELT), integrating valuation, trading, ownership, analyst perspectives, investor feedback, engagement, and upcoming catalysts.
Synthesize internal business updates and external research into conclusions on performance, risks, opportunities, and market perceptions; conduct ad hoc IR analyses and recommend communication priorities for senior leadership.
Education:
Bachelors Degree (BA/BS) Finance, or a closely related specialized field, with coursework directly related to financial statement analysis, corporate finance, valuation, and capital markets. A Business Administration degree must include a relevant finance or accounting concentration. - Required
Master's degree in Finance or a related specialized field, or MBA with a finance concentration - Preferred
Experience:
3 years or more in 1-3 years of experience in investor relations, equity research, investment banking, capital markets, corporate finance, or a related analytical role.
1 year or more in Experience in a publicly traded company, financial institution or financial services firm; healthcare or pharmaceutical industry exposure, particularly biosimilars, is a plus.
Specialized Knowledge:
Demonstrated application of f

> History, not a promise: past H-1B filings do not mean an employer will sponsor you or a given role. Data: U.S. DOL OFLC LCA disclosure (FY2024–FY2026 for role counts, certified LCAs) and the USCIS H-1B Employer Data Hub. Not legal advice. Methodology: https://visajobs.io/methodology
